Latest News
BrightFocus funds investigator-initiated research around the globe on a wide range of approaches to understanding and intervening with the biological mechanisms of dementia. The foundation has a strong record of support for innovative research ideas from scientists in the early stages of their careers.
Learn how monocytes have shown a reduced ability to ingest waste particles, and glatiramer acetate, a drug approved to treat multiple sclerosis, showed promise in treating AMD.
WHAM, BrightFocus Foundation Join Together to Promote Increased Funding for Women-Focused Alzheimer’s Research.
Learn about how researchers were able to predict the onset of Alzheimer’s disease (AD) using MRI.
Leading scientists share research to end Alzheimer’s and vision diseases during BrightFocus Foundation’s 6th Annual Gala.
Learn about how an international research team studying a form of dry age-related macular degeneration (AMD) discovered that two drugs used to treat human immunodeficiency virus (HIV), the virus that can lead to AIDS can block the retinal pigment epithelium (RPE) degeneration found in AMD.
Learn about a new 3D model of the neurovascular unit which helps to study how the vasculature contributes to neurodegenerative disease.
Learn about an implantable wireless device has identified new ways to help physicians diagnose and monitor glaucoma.
Learn about how researchers made a more accurate model of Alzheimer's disease using skin cells.